Richard D Friend, MD - Medicare Family Practice in Tuscaloosa, AL

Richard D Friend, MD is a medicare enrolled "Family Medicine" physician in Tuscaloosa, Alabama. He went to Tulane University School Of Medicine and graduated in 1993 and has 31 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Capstone Health Services Foundation Pc and his current practice location is 850 Peter Bryce Blvd, Tuscaloosa, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 348-1770.

Richard D Friend is licensed to practice in Louisiana (license number 10815R) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1023038684.

Contact Information

Richard D Friend, MD
850 Peter Bryce Blvd,
Tuscaloosa, AL 35401-7419
(205) 348-1770
(205) 348-1772



Physician's Profile

Full NameRichard D Friend
GenderMale
SpecialityFamily Practice
Experience31 Years
Location850 Peter Bryce Blvd, Tuscaloosa, Alabama
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Richard D Friend attended and graduated from Tulane University School Of Medicine in 1993
  NPI Data:
  • NPI Number: 1023038684
  • Provider Enumeration Date: 07/19/2006
  • Last Update Date: 07/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 6204807738
  • Enrollment ID: I20130502000566

Medical Identifiers

Medical identifiers for Richard D Friend such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023038684NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 18480 (Mississippi)Secondary
207Q00000XFamily Medicine 10815R (Louisiana)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Capstone Health Services Foundation Pc6103724489120

News Archive

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

Topline results from Janssen bapineuzumab Phase 3 trial on mild-to-moderate Alzheimer's

Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).

UK government declares identification of a "new variant" of coronavirus

The UK government has released a statement that a "new variant" of coronavirus that could be causing a faster spread of the virus has been identified.

Intake of green leafy vegetables reduces risk of developing type 2 diabetes

Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Richard D Friend allows following entities to bill medicare on his behalf.
Entity NameCapstone Health Services Foundation Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1740397751
PECOS PAC ID: 6103724489
Enrollment ID: O20040330001160

News Archive

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

Topline results from Janssen bapineuzumab Phase 3 trial on mild-to-moderate Alzheimer's

Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).

UK government declares identification of a "new variant" of coronavirus

The UK government has released a statement that a "new variant" of coronavirus that could be causing a faster spread of the virus has been identified.

Intake of green leafy vegetables reduces risk of developing type 2 diabetes

Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

Read more Medical News

› Verified 6 days ago

Entity NameParagon Contracting Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1225071459
PECOS PAC ID: 3971417825
Enrollment ID: O20050218000756

News Archive

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

Topline results from Janssen bapineuzumab Phase 3 trial on mild-to-moderate Alzheimer's

Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).

UK government declares identification of a "new variant" of coronavirus

The UK government has released a statement that a "new variant" of coronavirus that could be causing a faster spread of the virus has been identified.

Intake of green leafy vegetables reduces risk of developing type 2 diabetes

Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard D Friend is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Richard D Friend, MD
850 Peter Bryce Blvd,
Tuscaloosa, AL 35401-7419

Ph: (205) 348-1770
Richard D Friend, MD
850 Peter Bryce Blvd,
Tuscaloosa, AL 35401-7419

Ph: (205) 348-1770

News Archive

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

Topline results from Janssen bapineuzumab Phase 3 trial on mild-to-moderate Alzheimer's

Pfizer Inc. announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI)-led Phase 3 trial of intravenous (IV) bapineuzumab in patients with mild-to-moderate Alzheimer's disease who do not carry the ApoE4 (apolipoprotein E epsilon 4) genotype (Study 301).

UK government declares identification of a "new variant" of coronavirus

The UK government has released a statement that a "new variant" of coronavirus that could be causing a faster spread of the virus has been identified.

Intake of green leafy vegetables reduces risk of developing type 2 diabetes

Eating more green leafy vegetables can significantly reduce the risk of developing type 2 diabetes, finds research published today on bmj.com.

Arthritis drugs not as risky as first thought

Researchers now say that two biotech drugs used to treat rheumatoid arthritis, Humira (Abbott Laboratories) and Remicade (Johnson & Johnson), may not raise the risk of cancer and infections as much as was initially feared.

Read more News

› Verified 6 days ago


Family Medicine Doctors in Tuscaloosa, AL

Dr. Ashok V Mujumdar, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1700 University Blvd E, Tuscaloosa, AL 35404
Phone: 205-554-4196    Fax: 205-554-4196
Tameka Carmichael Hairston, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 850 Peter Bryce Blvd, Tuscaloosa, AL 35401
Phone: 205-348-1770    Fax: 205-348-1772
Dr. Subhod Rao, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 850 5th Ave E, Tuscaloosa, AL 35401
Phone: 205-348-1770    Fax: 205-348-7216
Dorian Christine Bonam, DO
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 2730 M. L King Jr Blvd, Tuscaloosa, AL 35403
Phone: 205-349-3250    
Dr. Stephen A Roberts, D.O.
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 1771 Skyland Blvd E, Tuscaloosa, AL 35405
Phone: 205-553-0199    Fax: 205-553-3024
David Maxwell, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 750 5th Avenue East, Tuscaloosa, AL 35401
Phone: 205-348-6262    Fax: 205-348-0630

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.